Justin Balko

Justin Balko is a Professor of Medicine in the Hematology and Oncology Division at Vanderbilt University School of Medicine. He is based at the Vanderbilt-Ingram Cancer Center, where his laboratory conducts research focused on enhancing anti-tumor immune responses through multimodal therapeutic strategies. His work bridges preclinical models and clinical translation in cancer immunotherapy.

His research interests lie at the intersection of oncology and immunology, particularly in understanding how combination therapies can activate the immune system to target and eliminate cancer cells. Utilizing both in vitro and in vivo mouse models, as well as clinical samples, his lab aims to identify effective immunotherapeutic approaches for cancer treatment. This translational focus positions his work to directly impact patient outcomes in hematologic and solid malignancies.

The trends in his research, though specific publications are not listed, indicate a strong emphasis on immuno-oncology, tumor microenvironment modulation, and combination therapy efficacy. His work integrates molecular pharmacology with immunological assessment, reflecting his dual training in pharmacy and biomedical sciences.

• Scientific awards: No specific awards mentioned in the provided text.

Dr. Balko mentors trainees in cancer research and leads a laboratory team focused on therapeutic development. While no formal advisees are listed, his role as a principal investigator suggests involvement in training graduate students, postdoctoral fellows, and clinical researchers. His lab is located in the 777 Preston Research Building, part of the integrated research infrastructure at Vanderbilt University Medical Center.